Table 2.
Characteristic | n (%)a |
---|---|
Age (years) [median (IQR)] | 76 (70.25-82.25) |
Male sex; n (%) | 9 (56.2) |
Underlying diseases; n (%) | |
Diabetes mellitus | 2 (12.5) |
Cardiovascular disease | 4 (25) |
Respiratory tract disease | 1 (6.2) |
Neurological disorder | 4 (25) |
Immunosuppressive therapy | 2 (12.5) |
Solid organ transplantation | 1 (6.2) |
Haematological malignancy | 1 (6.2) |
Chronic renal failure | 3 (18.7) |
Psiquiatric disorders | 2 (12.5) |
Oral anticoagulation | 4 (25) |
Age-adjusted Charlson CI [median (IQR)] | 3 (3-5) |
Surgical approach; n (%) | |
No surgery | 2 (12.5) |
DAIR | 2 (13.3) |
One stage | 0 (0) |
Two stage | 8 (53.3) |
Girdlestone | 2 (13.3) |
Data are n (%) unless otherwise stated; IQR, interquartile range; HIV, human immunodeficiency virus.